文献速递颈动脉与弓上血管

放疗所致颈动脉狭窄患者颈动脉干预的临床结局:倾向性评分匹配队列研究

Clinical Outcomes Following Carotid Intervention in Patients with Radiation-Induced Carotid Artery Stenosis: A Propensity Score-matched Cohort Study.
PubMed 文献 · Ann Vasc Surg · 2025-06-27

本研究回顾性比较2015至2024年接受经股动脉颈动脉支架置入术(TFCAS)的放疗所致颈动脉狭窄(RICS)与无RICS患者,经2:1倾向性评分匹配后30天和中期复合结局无显著差异,但RICS组再干预中再次支架置入率显著更高。本机构结局与东南血管研究组(SEVSG)数据无显著差异。

要点

  • RICS患者TFCAS术后30天卒中、TIA、心梗或死亡复合结局与无RICS者无差异。
  • 中期复合结局、再狭窄率和再干预率两组无显著差异。
  • 需再干预的患者中,RICS组再次支架置入率显著高于无RICS组。

核心结论

  • TFCAS对RICS患者是安全的,30天临床结局与无RICS组无差异。
  • 中期随访再干预率无差异,但RICS患者再次支架置入率显著更高。
  • 本机构结局与SEVSG区域数据相似。

研究设计与样本

  • 回顾性队列研究,纳入2015至2024年接受TFCAS的成人患者。
  • 共208例,无RICS组177例,RICS组31例;经2:1倾向性评分匹配后比较93例。
  • 匹配变量为症状状态和糖尿病。

主要发现

  • 30天同侧卒中、TIA、MI和死亡复合结局:无RICS组3.2% vs RICS组3.2%,P=1.00。
  • 中期同侧卒中、TIA、MI和死亡复合结局:无RICS组16.1% vs RICS组6.5%,P=0.19。
  • 再狭窄率:无RICS组22.6% vs RICS组12.9%,P=0.27。
  • 再干预率:无RICS组21% vs RICS组9.7%,P=0.17。
  • 需再干预患者中再次支架置入率:无RICS组0% vs RICS组6.5%,P=0.04。

关键数值与推荐

  • RICS放疗后颈动脉狭窄发生率可达27%。
  • 主要结局为30天卒中、TIA、MI或死亡复合终点。

临床怎么用

  • RICS患者可考虑TFCAS,围术期结局与无RICS者相当。
  • RICS患者需再干预时再次支架置入风险较高,应加强随访。

局限性

  • 回顾性单中心设计,样本量有限,RICS组仅31例。
  • 原文未报告更长期随访及多变量校正细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiation therapy, often combined with surgical excision is widely used in treating head and neck neoplasms. A long-term consequence of this therapy is radiation-induced carotid artery stenosis (RICS), with incidence rates reaching 27%. This study aimed to compare clinical outcomes in patients who underwent transfemoral carotid artery stenting (TFCAS) with and without RICS. Secondly, we compared our institution's outcomes with those from the Southeastern Vascular Study Group (SEVSG). METHODS: We conducted a retrospective cohort study in adult patients undergoing TFCAS from 2015 to 2024. Patients were categorized as having RICS and no-RICS. The main outcome was the composite of stroke, transient ischemic attack (TIA), myocardial infarction (MI), or death at 30 days. Secondary outcomes included mid-term composite outcomes of stroke, MI, TIA, and death, and individual rates of restenosis and reinterventions. A 2:1 propensity score matching was performed using logistic regression to control for symptomatic status and diabetes mellitus. RESULTS: A total of 208 patients were included, with 177 in the no-RICS and 31 in the RICS group. After propensity score matching, 93 patients were compared. The 30-day composite outcome of ipsilateral stroke, TIA, MI, and death was not different between groups (no-RICS: 3.2% vs. RICS: 3.2%; P = 1.00). At mid-term follow-up, the composite outcome of ipsilateral stroke, TIA, MI, and death was not significantly different (no-RICS:16.1% vs. RICS:6.5%; P = 0.19). There were no differences in the rate of restenosis (no-RICS: 22.6% vs. RICS: 12.9%; P = 0.27) and reinterventions (no-RICS: 21% vs. RICS: 9.7%; P = 0.17) between the groups. However, among the patients who needed reintervention, the RICS cohort had a significantly higher restenting rate than the no-RICS cohort (no-RICS: 0% vs. RICS: 6.5%, P = 0.04). No significant difference was found when comparing the SEVSG dataset with our cohort in 30 days or mid-term outcomes. CONCLUSION: TFCAS is a safe procedure for patients with RICS, as 30-day clinical outcomes, including stroke, TIA, MI, and death, do not differ from those in the no-RICS group. On mid-term follow-up, although the rate of reinterventions was not different among the cohorts, RICS patients had a significantly higher rate of restenting. In a larger cohort comparison, including the SEVSG, we found our institution's outcomes similar to those within our region.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jeevaratnam S, Meschia JF, Huang J, et al. Clinical Outcomes Following Carotid Intervention in Patients with Radiation-Induced Carotid Artery Stenosis: A Propensity Score-matched Cohort Study. Ann Vasc Surg. 2025. PMID: 40582456. doi:10.1016/j.avsg.2025.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。